Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -239,284 | -177,565 | -117,148 | -52,454 | -141,965 |
| Depreciation Amortization | 776 | 568 | 369 | 180 | 627 |
| Accounts receivable | N/A | 1,760 | 1,760 | N/A | 8,053 |
| Accounts payable and accrued liabilities | 2,806 | -5,214 | -4,553 | -2,389 | 4,305 |
| Other Working Capital | -11,073 | -17,873 | -16,267 | -18,031 | 24,792 |
| Other Operating Activity | 92,307 | 76,887 | 51,269 | 22,671 | 26,985 |
| Operating Cash Flow | $-154,468 | $-121,437 | $-84,570 | $-50,023 | $-77,203 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,181 | -1,122 | -970 | -614 | -1,292 |
| Purchase Of Investment | -214,806 | -211,783 | -186,720 | -104,838 | -132,259 |
| Sale Of Investment | 133,222 | 90,457 | 66,891 | 52,769 | 70,277 |
| Other Investing Activity | -3,098 | -3,097 | 0 | 0 | -1 |
| Investing Cash Flow | $-85,863 | $-125,545 | $-120,799 | $-52,683 | $-63,275 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 233,361 | 232,041 | 226,667 | 219,633 | 135,973 |
| Financing Cash Flow | $233,361 | $232,041 | $226,667 | $219,633 | $135,973 |
| Beginning Cash Position | 38,539 | 38,539 | 38,539 | 38,539 | 43,044 |
| End Cash Position | 31,569 | 23,598 | 59,837 | 155,466 | 38,539 |
| Net Cash Flow | $-6,970 | $-14,941 | $21,298 | $116,927 | $-4,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -154,468 | -121,437 | -84,570 | -50,023 | -77,203 |
| Capital Expenditure | -1,181 | -1,122 | -970 | -614 | -1,292 |
| Free Cash Flow | -155,649 | -122,559 | -85,540 | -50,637 | -78,495 |